Cognitive-adaptive disabilities

Pediatr Clin North Am. 2011 Feb;58(1):189-203, xii. doi: 10.1016/j.pcl.2010.10.003.

Abstract

Cognitive-adaptive disabilities (CADs) are not frequently seen in the general pediatric setting. Yet, given the high rates of comorbidity in that population, they commonly demand a lot of time and effort on the part of clinicians. One aspect of comorbidity is the degree to which psychiatric disorders occur in children, adolescents, and young adults with CADs. This article reviews the epidemiology, associated psychopathology, and pharmacologic treatment of selected CADs.

Publication types

  • Review

MeSH terms

  • Adolescent
  • Child
  • Child Development Disorders, Pervasive / drug therapy
  • Child Development Disorders, Pervasive / epidemiology
  • Child Development Disorders, Pervasive / psychology
  • Cognition Disorders / drug therapy*
  • Cognition Disorders / epidemiology
  • Cognition Disorders / psychology
  • Comorbidity
  • Developmental Disabilities / drug therapy*
  • Developmental Disabilities / epidemiology
  • Developmental Disabilities / psychology
  • DiGeorge Syndrome / drug therapy
  • DiGeorge Syndrome / epidemiology
  • DiGeorge Syndrome / psychology
  • Down Syndrome / drug therapy
  • Down Syndrome / epidemiology
  • Down Syndrome / psychology
  • Female
  • Fetal Alcohol Spectrum Disorders / drug therapy
  • Fetal Alcohol Spectrum Disorders / epidemiology
  • Fetal Alcohol Spectrum Disorders / psychology
  • Fragile X Syndrome / drug therapy
  • Fragile X Syndrome / epidemiology
  • Fragile X Syndrome / psychology
  • Humans
  • Male
  • Neurofibromatosis 1 / drug therapy
  • Neurofibromatosis 1 / epidemiology
  • Neurofibromatosis 1 / psychology
  • Pregnancy
  • Tuberous Sclerosis / drug therapy
  • Tuberous Sclerosis / epidemiology
  • Tuberous Sclerosis / psychology